TCRX Competitors & Alternatives
Compare Tscan Therapeutics Inc with similar stocks in the same industry
Biotechnology
TCRX
Main Stock$0.21
Tradestie Score
54
Market Cap
$118.60M
Revenue Growth
-0.7%
Analyst Upside
+369.2%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.08
|
$154.27M | - | 60 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.05
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.38
|
$114.01M | - | 63 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.10
|
$112.28M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.46
|
$110.20M | - | 57 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$1.93
|
$106.00M | - | 60 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.91
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.93
|
$67.94M | - | 60 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$1.49
|
$43.18M | - | 33 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.05
|
$10.26M | - | 45 | Compare |
More TCRX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry